🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound

RecruitingNAAges 50 Years - 75 YearsMaleFondation Ophtalmologique Adolphe de Rothschild
NCT05617326 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Abdominal aortic aneurysm (AAA) is a localized dilatation of a segment of the aorta artery in its abdominal portion. It affects 1.7% of men aged 65 years and older. In the high-risk population (male smokers aged 65-75 years), its prevalence is estimated to be between 2.8 and 9%. Mortality of ruptured AAAs is high (80% of deaths before hospitalization or perioperatively), whereas mortality of scheduled procedures for unruptured AAAs is less than 5%. AAA screening has been shown to significantly reduce the specific mortality rate in the medium and long term. The French National Authority for Health (HAS) recommends targeted screening for AAA by ultrasound at the radiologist. The target population is male smokers or former smokers aged 65 to 75 years, as well as all persons aged 50 to 75 years with a family history of AAA. Despite recommendations, the rate of access to targeted screening ap

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male * In the absence of a family history of AAA: Patient aged 65 to 75 years, chronic current or past smoker, active smoker (defined as having smoked at least one cigarette per day) or former smoker (defined as having quit smoking less than 20 years ago, regardless of the number of cigarettes smoked). * If there is a family history of AAA: Patient between 50 and 75 years of age * Express consent to participate in the study * Affiliated or beneficiary of a social security plan Exclusion Criteria: * Patient with a legal protection measure * Patient with previous AAA screening less than 5 years old * Patient unable to understand the study / give informed consent (cognitive impairment, communication impairment)
💊

What it tests

  • AAA screening by a GP
  • AAA screening by a radiologist
📍

Where

6 sites
Cabinet IPSO Brotteaux
Lyon, France
Cabinet IPSO Saint Martin
Paris, France
Cabinet IPSO Nation
Paris, France
Cabinet IPSO Richard-Lenoir
Paris, France
Cabinet IPSO Italie
Paris, France
Cabinet IPSO Ourcq
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy